Integrase Inhibitor

The introduction of long-acting injectable cabotegravir PrEP in sub-Saharan Africa could result in fewer future AIDS deaths and new infections, while being a cost-effective alternative to oral PrEP, according to a recent study.

In a cohort of patients with HIV, weight gain was linked to the use of certain types of ART, as well as a baseline diagnosis of hypertension, a researcher reported at IDWeek.

Integrase strand transfer inhibitors are associated with an increased risk for weight gain and hyperglycemia or diabetes, according to data presented at IDWeek.

Judith Feinberg, MD, from West Virginia University School of Medicine, spoke with Healio about important FDA approvals in HIV, the burden of drug resistance, threats to HIV control and the future of HIV treatment.

The role of mutations in the development of drug resistance among patients with HIV involves several factors, according to Alan Taege, MD, of the department of infectious disease at Cleveland Clinic.